Skip to main content
C.R. Bard's covered iliac stent gets premarket approval from FDA
6/26/2017

The FDA has given C.R. Bard premarket approval for its LifeStream covered iliac stent, a device intended for treating patients with peripheral artery disease. The approval is for the use of the device in treating atherosclerotic lesions in external and common iliac arteries with lesion lengths of up to 100 mm and diameters ranging from 4.5 mm to 12 mm.

Full Story: